AbbVie vs Merck: revenue, profit, margins and growth compared
AbbVie brought in $61.2B of revenue in fiscal 2025, Merck $65B in fiscal 2025. Revenue changed by +8.6% at AbbVie and +1.3% at Merck on the year before, so AbbVie grew faster. AbbVie kept 6.9% of its revenue as net profit, Merck 28.1%. Free cash flow was $17.8B at AbbVie and $12.4B at Merck.
Fiscal years as each company reports them; the two may end in different months.
Questions about AbbVie and Merck
Which is bigger by revenue, AbbVie or Merck?
Merck is bigger by revenue: $65B in fiscal 2025, against $61.2B for AbbVie in fiscal 2025.
Which keeps more of its revenue as profit, AbbVie or Merck?
AbbVie had a net margin of 6.9% in fiscal 2025; Merck had 28.1% in fiscal 2025.
Which grew revenue faster, AbbVie or Merck?
In their latest fiscal years revenue changed by +8.6% at AbbVie and +1.3% at Merck.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.